Comparative analyses of the mutation site distribution for TET1 and ELF3 reveal that TET1 mutations are enriched in UCEC and SKCM, while ELF3 mutation sites are significantly concentrated in BLCA (Figure 1C). The gene discussed is TET1; the disease is bladder transitional cell carcinoma.